In the AD model, Trem2 expression was suppressed, enhancing nuclear factor‐κB (NF‐κB) signaling and promoting the secretion of pro‐inflammatory factors such as tumor necrosis factor‐α (TNF‐α) and interleukin‐6 (IL‐6). Here, NFKB1 is linked to Alzheimer disease.